Evidence map›Paper›PMID 42076641›Full record

ArticleSensors (Basel, Switzerland)2026

AcneFormer: A Lesion-Aware and Noise-Robust CNN-Transformer for Acne Image Classification.

Yongtao Zhou, Kui Zhao

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yongtao ZhouSchool of Cyber Science and Engineering, Sichuan University, Chengdu 610207, China.ORCID 0009-0008-7757-5239
Kui ZhaoSchool of Cyber Science and Engineering, Sichuan University, Chengdu 610207, China.

Funding

National Natural Science Foundation of China 62162057Science and Technology Department of Sichuan Province 2022YFG0182
6 · The paper itself

Abstract

Convolutional neural networks (CNNs) have been widely used for acne image classification due to their effectiveness in capturing local texture of skin lesions. However, the locality of convolution operations limits their ability to model long-range dependencies. Vision Transformer (ViT) methods address this issue to some extent but their high computational complexity and reliance on large-scale pre-training present challenges. Although CNN-Transformer architecture alleviates this conflict to some extent, acne images present task-specific challenges, including indistinct lesion boundaries, subtle inter-class variations, and various facial interference factors. In this paper, we propose AcneFormer, a lesion-aware and noise-robust CNN-Transformer architecture for acne image classification. We introduce three modules especially for acne tasks: a Lesion Cue Enhancement (LCE) module to highlight discriminative multi-scale spatial patterns, a Cross-Layer Feature Transmission (CLFT) module to enhance cross-layer information flow in Transformers, and a Differential Semantic Denoising (DSD) module to suppress irrelevant responses during deep feature interaction. Extensive experiments show that AcneFormer outperforms several strong baselines. Ablation and external lesion-annotated analyses further show a consistent pattern: LCE mainly improves lesion-sensitive localization and class-balanced recognition, CLFT expands valid cross-depth lesion evidence, and DSD suppresses off-lesion semantic responses.

Indexed as

Acne VulgarisImage Processing, Computer-AssistedAlgorithmsConvolutional Neural NetworksHumansNeural Networks, Computeracne classificationconvolutional neural networkmedical image processingvision transformer

Identifiers

PMID42076641
PMCPMC13120028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.